Ask AI
H.R. 4966

Preventing Superbugs and Protecting Patients Act

Preventing Superbugs and Protecting Patients Act

This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to identify types of medical devices for which premarket notification must include proposed labeling, including validated instructions regarding cleaning, disinfection, and sterilization.

The FDA must issue final guidance regarding when a premarket notification is required for a modification to a medical device.

Referred to the Subcommittee on Health.

Rep. Lieu, Ted [D-CA-33](D-CA)Sponsor
8 cosponsors7 D1 R
8cosponsors1committees4actions2related bills7subjects
  1. Committee

    Referred to the Subcommittee on Health.

    Health Subcommittee
  2. IntroReferralH11100

    Referred to the House Committee on Energy and Commerce.

    Energy and Commerce Committee
  3. IntroReferralIntro-H

    Introduced in House

  4. IntroReferral1000

    Introduced in House

Preventing Superbugs and Protecting Patients Act — Informed